全文获取类型
收费全文 | 7872篇 |
免费 | 624篇 |
国内免费 | 23篇 |
专业分类
耳鼻咽喉 | 70篇 |
儿科学 | 244篇 |
妇产科学 | 214篇 |
基础医学 | 1062篇 |
口腔科学 | 117篇 |
临床医学 | 910篇 |
内科学 | 1425篇 |
皮肤病学 | 155篇 |
神经病学 | 959篇 |
特种医学 | 130篇 |
外科学 | 899篇 |
综合类 | 107篇 |
一般理论 | 9篇 |
预防医学 | 884篇 |
眼科学 | 158篇 |
药学 | 594篇 |
中国医学 | 42篇 |
肿瘤学 | 540篇 |
出版年
2024年 | 16篇 |
2023年 | 149篇 |
2022年 | 179篇 |
2021年 | 408篇 |
2020年 | 208篇 |
2019年 | 335篇 |
2018年 | 339篇 |
2017年 | 230篇 |
2016年 | 298篇 |
2015年 | 302篇 |
2014年 | 373篇 |
2013年 | 438篇 |
2012年 | 689篇 |
2011年 | 668篇 |
2010年 | 319篇 |
2009年 | 286篇 |
2008年 | 462篇 |
2007年 | 436篇 |
2006年 | 415篇 |
2005年 | 366篇 |
2004年 | 328篇 |
2003年 | 259篇 |
2002年 | 224篇 |
2001年 | 52篇 |
2000年 | 60篇 |
1999年 | 46篇 |
1998年 | 41篇 |
1997年 | 34篇 |
1996年 | 22篇 |
1995年 | 27篇 |
1994年 | 19篇 |
1993年 | 17篇 |
1992年 | 28篇 |
1991年 | 37篇 |
1990年 | 28篇 |
1989年 | 28篇 |
1988年 | 21篇 |
1987年 | 14篇 |
1986年 | 31篇 |
1985年 | 21篇 |
1984年 | 14篇 |
1983年 | 20篇 |
1982年 | 21篇 |
1981年 | 19篇 |
1980年 | 14篇 |
1978年 | 16篇 |
1977年 | 13篇 |
1975年 | 15篇 |
1974年 | 14篇 |
1973年 | 16篇 |
排序方式: 共有8519条查询结果,搜索用时 15 毫秒
91.
92.
93.
Elaine C. Khoong Natalie A. Rivadeneira Lucia Pacca Dean Schillinger David Lown Palav Babaria Neha Gupta Rajiv Pramanik Helen Tran Tyler Whitezell Ma Somsouk Urmimala Sarkar 《Journal of general internal medicine》2023,38(1):21
BackgroundInequitable follow-up of abnormal cancer screening tests may contribute to racial/ethnic disparities in colon and breast cancer outcomes. However, few multi-site studies have examined follow-up of abnormal cancer screening tests and it is unknown if racial/ethnic disparities exist.ObjectiveThis report describes patterns of performance on follow-up of abnormal colon and breast cancer screening tests and explores the extent to which racial/ethnic disparities exist in public hospital systems.DesignWe conducted a retrospective cohort study using data from five California public hospital systems. We used multivariable robust Poisson regression analyses to examine whether patient-level factors or site predicted receipt of follow-up test.Main MeasuresUsing data from five public hospital systems between July 2015 and June 2017, we assessed follow-up of two screening results: (1) colonoscopy after positive fecal immunochemical tests (FIT) and (2) tissue biopsy within 21 days after a BIRADS 4/5 mammogram.Key ResultsOf 4132 abnormal FITs, 1736 (42%) received a follow-up colonoscopy. Older age, Medicaid insurance, lack of insurance, English language, and site were negatively associated with follow-up colonoscopy, while Hispanic ethnicity and Asian race were positively associated with follow-up colonoscopy. Of 1702 BIRADS 4/5 mammograms, 1082 (64%) received a timely biopsy; only site was associated with timely follow-up biopsy.ConclusionDespite the vulnerabilities of public-hospital-system patients, follow-up of abnormal cancer screening tests occurs at rates similar to that of patients in other healthcare settings, with colon cancer screening test follow-up occurring at lower rates than follow-up of breast cancer screening tests. Site-level factors have larger, more consistent impact on follow-up rates than patient sociodemographic traits. Resources are needed to identify health system–level factors, such as test follow-up processes or data infrastructure, that improve abnormal cancer screening test follow-up so that effective health system–level interventions can be evaluated and disseminated.Supplementary InformationThe online version contains supplementary material available at 10.1007/s11606-022-07657-4.KEY WORDS: safety-net system, cancer screening, colon cancer, breast cancer, cancer disparities 相似文献
94.
Chongliang Luo Md Nazmul Islam Natalie E Sheils John Buresh Martijn J Schuemie Jalpa A Doshi Rachel M Werner David A Asch Yong Chen 《J Am Med Inform Assoc》2022,29(8):1366
ObjectiveTo develop a lossless distributed algorithm for generalized linear mixed model (GLMM) with application to privacy-preserving hospital profiling.Materials and MethodsThe GLMM is often fitted to implement hospital profiling, using clinical or administrative claims data. Due to individual patient data (IPD) privacy regulations and the computational complexity of GLMM, a distributed algorithm for hospital profiling is needed. We develop a novel distributed penalized quasi-likelihood (dPQL) algorithm to fit GLMM when only aggregated data, rather than IPD, can be shared across hospitals. We also show that the standardized mortality rates, which are often reported as the results of hospital profiling, can also be calculated distributively without sharing IPD. We demonstrate the applicability of the proposed dPQL algorithm by ranking 929 hospitals for coronavirus disease 2019 (COVID-19) mortality or referral to hospice that have been previously studied.ResultsThe proposed dPQL algorithm is mathematically proven to be lossless, that is, it obtains identical results as if IPD were pooled from all hospitals. In the example of hospital profiling regarding COVID-19 mortality, the dPQL algorithm reached convergence with only 5 iterations, and the estimation of fixed effects, random effects, and mortality rates were identical to that of the PQL from pooled data.ConclusionThe dPQL algorithm is lossless, privacy-preserving and fast-converging for fitting GLMM. It provides an extremely suitable and convenient distributed approach for hospital profiling. 相似文献
95.
Poor pain assessment is cited as one barrier to the adequate treatment of cancer pain. The identification of relevant psychosocial factors may improve the assessment of chronic cancer pain. This article presents: 1) a critical review of the evidence for an association between chronic cancer pain and psychological distress, social support, and coping; 2) clinical implications of the findings; and 3) recommendations for future research. Fourteen of the 19 reviewed studies on psychological distress found a significant association between increased pain and increased distress. Seven of the eight studies on social support found significant association between higher levels of pain and decreased levels of social activities and social support. Three of the four studies that examined coping strategies found that increased catastrophizing was significantly associated with more intense pain. Based on several criteria, the evidence is considered Strong for psychological distress, Moderate for social support, and Inconclusive for coping. This review suggests that comprehensive chronic pain assessment should include routine screening for psychological distress. 相似文献
96.
Roda Matilde Pazzaglia Alberto Guaraldi Fabio Taroni Leonardo Natalie di Geronimo Fresina Michela Schiavi Costantino 《Indian journal of ophthalmology》2022,70(2):673
A 41-year-old man presented to the emergency department complaining of decrease of vision in his left eye. Initial examination was consistent with retrobulbar optic neuritis, and an intravenous drip of methylprednisolone was started. On the third day, the fundus examination revealed the appearance of multiple Purtscher-like cotton-wool spots in the posterior pole and nasally to the optic disc, slight retinal whitening around the fovea, and cherry-red spot. The patient reported flu-like symptoms, and he tested positive at PCR (polymerase chain reaction) test for 2019-nCoV (2019 novel coronavirus) infection. Assuming possible 2019-nCoV-related vascular damage, we prescribed low-molecular-weight heparin. The lesions were regressing at follow-up, and we registered a complete visual recovery. 相似文献
97.
98.
Shaji Kumar Lawrence Baizer Natalie S. Callander Sergio A. Giralt Jens Hillengass Boris Freidlin Antje Hoering Paul G. Richardson Elena I. Schwartz Anthony Reiman Suzanne Lentzsch Philip L. McCarthy Sundar Jagannath Andrew J. Yee Richard F. Little Noopur S. Raje 《Blood cancer journal》2022,12(6)
A wide variety of new therapeutic options for Multiple Myeloma (MM) have recently become available, extending progression-free and overall survival for patients in meaningful ways. However, these treatments are not curative, and patients eventually relapse, necessitating decisions on the appropriate choice of treatment(s) for the next phase of the disease. Additionally, an important subset of MM patients will prove to be refractory to the majority of the available treatments, requiring selection of effective therapies from the remaining options. Immunomodulatory agents (IMiDs), proteasome inhibitors, monoclonal antibodies, and alkylating agents are the major classes of MM therapies, with several options in each class. Patients who are refractory to one agent in a class may be responsive to a related compound or to a drug from a different class. However, rules for selection of alternative treatments in these situations are somewhat empirical and later phase clinical trials to inform those choices are ongoing. To address these issues the NCI Multiple Myeloma Steering Committee formed a relapsed/refractory working group to review optimal treatment choices, timing, and sequencing and provide recommendations. Additional issues considered include the role of salvage autologous stem cell transplantation, risk stratification, targeted approaches for genetic subsets of MM, appropriate clinical trial endpoints, and promising investigational agents. This report summarizes the deliberations of the working group and suggests potential avenues of research to improve the precision, timing, and durability of treatments for Myeloma.Subject terms: Combination drug therapy, Cancer therapeutic resistance, Targeted therapies 相似文献
99.